文献速递重症综合管理与镇静镇痛心脑血管急症创伤与烧伤

限制性与宽松性输血策略在创伤性脑损伤患者中的疗效:随机对照试验的系统评价与荟萃分析

Efficacy of restrictive versus liberal transfusion strategies in patients with traumatic brain injury: a systematic review and meta-analysis of randomized controlled trials.
PubMed 文献 · Ann Intensive Care · 2024-11-28
一句话结论在成人中重度创伤性脑损伤患者中,限制性输血策略与宽松性输血策略相比未降低死亡率(RR 1.00)或6个月不良神经功能结局(RR 1.06),但减少了输注红细胞单位数(MD -2.62)。

该系统评价与荟萃分析检索了PubMed、EMBASE和Cochrane Central Register of Controlled Trials自建库至2024年10月20日的随机对照试验,比较限制性输血(血红蛋白≤7 g/dL时输血)与宽松性输血(血红蛋白≤9-10 g/dL时输血)策略在成人创伤性脑损伤患者中的效果。共纳入5项随机对照试验、1528例患者。结果显示,限制性输血与宽松性输血相比,对死亡率(RR 1.00,95%CI 0.80-1.24,I²=0%)和6个月不良神经功能结局(RR 1.06,95%CI 0.94-1.20,I²=47%)均无显著影响;限制性输血与输注红细胞单位数减少相关(MD -2.62,95%CI -3.33至-1.90,I²=63%)。作者结论认为,在创伤性脑损伤患者中,限制性输血策略与宽松性输血策略相比未降低死亡风险或不良神经功能结局风险。

要点

  • 成人中重度创伤性脑损伤患者中,限制性输血(血红蛋白≤7 g/dL时输血)与宽松性输血(血红蛋白≤9-10 g/dL时输血)相比,死亡率无显著差异(RR 1.00,95%CI 0.80-1.24,I²=0%)。
  • 限制性输血与宽松性输血相比,6个月不良神经功能结局(GOS<4或GOSE<6)无显著差异(RR 1.06,95%CI 0.94-1.20,I²=47%)。
  • 限制性输血与宽松性输血相比,输注红细胞单位数减少(MD -2.62,95%CI -3.33至-1.90,I²=63%)。

适用人群与场景

  • 成人中重度创伤性脑损伤合并贫血的危重症患者。

诊断标准与关键阈值

  • 限制性输血策略:血红蛋白≤7 g/dL时输血。
  • 宽松性输血策略:血红蛋白≤9-10 g/dL时输血。
  • 不良神经功能结局:6个月时Glasgow结局量表(GOS)<4分或Glasgow结局量表扩展版(GOSE)<6分。

研究设计与关键结果

  • 研究类型:随机对照试验的系统评价与荟萃分析;检索PubMed、EMBASE和Cochrane Central Register of Controlled Trials自建库至2024年10月20日。
  • 纳入5项随机对照试验,共1528例成人创伤性脑损伤患者,比较限制性输血(血红蛋白≤7 g/dL时输血)与宽松性输血(血红蛋白≤9-10 g/dL时输血)策略。
  • 主要终点死亡率:限制性输血与宽松性输血相比无显著差异(RR 1.00,95%CI 0.80-1.24,I²=0%)。
  • 次要终点6个月不良神经功能结局(GOS<4或GOSE<6):限制性输血与宽松性输血相比无显著差异(RR 1.06,95%CI 0.94-1.20,I²=47%)。
  • 次要终点输注红细胞单位数:限制性输血与宽松性输血相比减少(MD -2.62,95%CI -3.33至-1.90,I²=63%)。

证据类型、等级与局限

  • 证据类型:随机对照试验的系统评价与荟萃分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在成人中重度创伤性脑损伤患者中,限制性输血策略(血红蛋白≤7 g/dL时输血)与宽松性输血策略(血红蛋白≤9-10 g/dL时输血)相比未降低死亡率或6个月不良神经功能结局风险,但减少了输注红细胞单位数。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The effects of restrictive versus liberal transfusion strategies in critically ill patients with traumatic brain injury (TBI) and anemia, particularly in adult patients with moderate to severe TBI, remain inconclusive. Therefore, this systematic review and meta-analysis aim to evaluate the comparative impact of restrictive and liberal red blood cell transfusion strategies among critically ill adult patients with moderate to severe TBI.

METHODS: We conducted a search of PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials from their inception through October 20, 2024, to identify randomized controlled trials that compared restrictive (transfusions at a hemoglobin level of ≤ 7 g/dL) and liberal (transfusions at a hemoglobin level of ≤ 9-10 g/dL) transfusion strategies in adult patients with TBI. The primary outcome was mortality, with secondary outcomes including an unfavorable neurological outcome at six months, as determined by the Glasgow Outcome Scale (GOS < 4; or Glasgow Outcome Scale-Extended [GOSE] < 6), and the number of units of packed red blood cells (pRBCs) transfused.

RESULTS: Five randomized controlled trials involving 1,528 patients were included in the analysis. The results showed that restrictive transfusion, compared to liberal transfusion, had no impact on mortality (RR 1.00, 95% CI 0.80 to 1.24, I2 = 0%) or unfavorable neurological outcome at 6 months (RR 1.06, 95% CI 0.94 to 1.20, I2 = 47%). Restrictive transfusion was associated with a reduction in the number of units of pRBCs transfused (MD -2.62, 95% CI -3.33 to -1.90, I2 = 63%).

CONCLUSION: In patients with TBI, a restrictive transfusion strategy did not reduce the risk of mortality or unfavorable neurological outcome compared with a liberal transfusion strategy.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Yuan X, Zhang S, Wan J, et al. Efficacy of restrictive versus liberal transfusion strategies in patients with traumatic brain injury: a systematic review and meta-analysis of randomized controlled trials. Ann Intensive Care. 2024. PMID: 39607477. doi:10.1186/s13613-024-01411-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。